| PMID |
12901835 ( ![]() ![]() ![]() ) |
|---|---|
| Title | Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. |
| Abstract | We report that the expression of mutant G93A copper/zinc superoxide dismutase (SOD1), associated with familial amyotrophic lateral sclerosis, specifically causes a decrease in MTT reduction rate and ATP levels and an increase in both cytosolic and mitochondrial reactive oxygen species (ROS) production in human neuroblastoma SH-SY5Y cells compared to cells overexpressing wild-type SOD1 and untransfected cells. Exposure to N-acetylcysteine lowers ROS production and returns mitochondrial functional assays to control levels. No large aggregates of human SOD1 are detectable under basal growth conditions in any of the investigated cell lines. After proteasome activity inhibition, SOD1 aggregates can be detected exclusively in G93A-SOD1 cells, even though they do not per se enhance cell death compared to control cell lines. Our findings indicate that mitochondrial homeostasis is affected by mutant SOD1-generated ROS independently from the formation of aggregates and that this alteration is reversed by antioxidants. Milano-Bicocca, San Gerardo Hospital, via Donizetti, 106, 20052, Monza (MI), Italy. |
NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.
Targets by SciMiner Summary
| HUGO ID | Symbol | Target Name | #Occur | ActualStr |
|---|---|---|---|---|
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 41 | SOD1-generated | SOD1-positive | SOD1-linked | SOD1s | superoxide dismutase | sod1 | |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | 2 | caspase 3 | |
| 1613 | CCS | copper chaperone for superoxide dismutase | 2 | CCS | |
| 7808 | NGF | nerve growth factor (beta polypeptide) | 2 | nerve growth factor | NGF | |
| 31395 | COX8B | cytochrome c oxidase, subunit 8B pseudogene | 1 | cytochrome c oxidase | |
| 7688 | NDUFA5 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa | 1 | ubiquinone reductase | |
Targets by SciMiner Full list
| HUGO ID | Symbol | Name | ActualStr | Score | FlankingText |
|---|---|---|---|---|---|
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | expression of mutant G93A copper/zinc copper zinc superoxide dismutase (SOD1), SOD1 associated with familial amyotrophic lateral sclerosis specifically causes a decrease |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | in human neuroblastoma SH-SY5Y cells compared to cells overexpressing wild-type SOD1 and untransfected cells |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | No large aggregates of human SOD1 are detectable under basal growth conditions in any of the |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1-generated | 1.9 | Our findings indicate that mitochondrial homeostasis is affected by mutant SOD1-generated ROS independently from the formation of aggregates and that this |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | coding for the antioxidant enzyme Cu Zn superoxide dismutase (SOD1) SOD1 Siddique et al 1991 Deng et al 1993 and Rosen |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | SOD1 typically has an antioxidant function because it removes the superoxide |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | sod1 | 2.4 | However mutations in sod1 gene do not cause FALS through simple loss of dismutating |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | et al 1993 several lines of evidence indicate that mutant SOD1s are responsible for the death of motor neurons through the |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | be responsible for the enhancement of the peroxidative activity of SOD1 as independently reported by two groups Wiedau-Pazos et al 1996 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | The second hypothesis relies on the observation that misfolded mutant SOD1s might release their metal ions (copper copper and zinc and |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | In particular decrease of the copper-buffering properties of SOD1 Steinkuhler et al 1991 could result in an increase of |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | It is not clear at present whether misfolded SOD1s would also bind copper ions and mediate increase in oxidative |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | neuron disease with mice devoid of the Copper Chaperone for SOD1 (CCS CCS _amp_#x2212;/_amp_#x2212;) _amp_#x2212 _amp_#x2212 does not rescue the phenotype |
| 1613 | CCS | copper chaperone for superoxide dismutase | CCS | 1.2 | with mice devoid of the Copper Chaperone for SOD1 (CCS CCS _amp_#x2212;/_amp_#x2212;) _amp_#x2212 _amp_#x2212 does not rescue the phenotype Subramaniam et |
| 1613 | CCS | copper chaperone for superoxide dismutase | CCS | 1.2 | However although it is most probable that CCS is not directly involved in ALS mishandling of copper is |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | as the major culprit in oxidative stress induced by mutant SOD1 Bush 2002 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | The recent demonstration that a substantial amount of SOD1 (previously previously thought of as being exclusively a cytosolic enzyme |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1-linked | 1.9 | reductase defects have been shown both in postmortem brains from SOD1-linked FALS patients Browne et al 1998 and in skeletal muscle |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | spinal motor neurons of transgenic mice carrying G93A mutant human SOD1 Warita et al 2001 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | by site-directed mutagenesis of the cDNA coding for that mutant SOD1 cloning in expression vectors and transfection of parental human neuroblastoma |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | using the Immun-blot kit from Bio-Rad with a polyclonal antihuman SOD1 antibody Steinkuhler et al 1991 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | for 2 h at 37_amp_#xb0 C with a monoclonal antimouse SOD1 antibody (Sigma) Sigma 1 300 and for 2 h at |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | 0.05 in line with the well-known protective role of wild-type SOD1 overexpression against free radicals |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | Aggregation of mutant SOD1 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | It has been suggested that aggregation of misfolded mutant SOD1 contributes to neurodegeneration in FALS |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | However it is still debated whether SOD1 aggregates represent a cause a correlate or a consequence of |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | In all of our lines no large aggregates of human SOD1 are detectable after immunostaining in basal growth conditions ( Fig |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | localized in the cytoplasm and roughly paralleled the level of SOD1 expression being more intense in transfected cells than in control |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1-positive | 1.9 | specifically inhibit the proteasome activity with lactacystin for 16 h SOD1-positive aggregates localize in the cytoplasm of 30_amp_#x2013 40% cells expressing |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | localize in the cytoplasm of 30_amp_#x2013 40% cells expressing mutant SOD1s but not in control cells |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | is paralleled by the appearance of an insoluble fraction containing SOD1 in extracts from cells expressing mutant SOD1 as seen in |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | insoluble fraction containing SOD1 in extracts from cells expressing mutant SOD1 as seen in Western blot experiments where detergent-soluble and -insoluble |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | to demonstrate that human neuroblastoma SH-SY5Y cell lines carrying G93A SOD1 mutation possess remarkable biochemical abnormalities compared to control cells such |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | This provides evidence that G93A SOD1 mutation acts as a remarkable source of intracellular oxidative stress |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | and mitochondrial ultrastructural abnormalities were found in animal models carrying SOD1 mutations Wong et al 1995 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | be a direct consequence of the pro-oxidant activity of mutant SOD1 indeed the use of NAC promptly reverts both increase in |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | survival and motor performance in transgenic mice with a G93A SOD1 mutation Andreassen et al 2000 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | When we specifically inhibit the proteasome activity insoluble SOD1 aggregates localize in the cytoplasm of cells expressing mutant SOD1s |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | SOD1 aggregates localize in the cytoplasm of cells expressing mutant SOD1s but not in control cells |
| 7808 | NGF | nerve growth factor (beta polypeptide) | NGF | 1.2 | is not causative of death in nerve growth factor (NGF)-differentiated NGF -differentiated PC12 cells transfected with mutant SOD1s (SODMT, SODMT V148G |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1s | 1.9 | growth factor (NGF)-differentiated NGF -differentiated PC12 cells transfected with mutant SOD1s (SODMT, SODMT V148G or A4V |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | survey on the properties of a large number of mutant SOD1 in vitro Hayward et al 2002 and Rodriguez et al |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | we report that the expression of mutant g93a copper/zinc superoxide dismutase sod1 associated with familial amyotrophic lateral sclerosis specifically causes a decrease in mtt reduction rate and atp levels and an increase in both cytosolic and mitochondrial reactive oxygen spe |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | in the early 1990s it has been demonstrated that about 20% of familial als fals patients possess point mutations in the gene coding for the antioxidant enzyme cu zn superoxide dismutase sod1 [ siddique et al 1991 deng et al 1993 and rosen et al 1993 ]. |
| 31395 | COX8B | cytochrome c oxidase, subunit 8B pseudogene | cytochrome c oxidase | 1.0 | decreased activity of cytochrome c oxidase was demonstrated in spinal cord motor neurons [ borthwick et al 1999 ] and lymphocytes [ curti et al 1996 ] from sals patients. |
| 7688 | NDUFA5 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa | ubiquinone reductase | 1.0 | nadh ubiquinone reductase defects have been shown both in postmortem brains from sod1 linked fals patients [ browne et al 1998 ] and in skeletal muscle from sals patients [ vielhaber et al 1999 ]. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | caspase 3 activity apoalert caspase 3 colorimetric assay kit clontech palo alto usa |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | neither caspase 3 activation fig 1b nor the number of condensed nuclei fig 1c_amp_#x2013;e was found to be significantly increased in g93a mutant cells indicating that no significant spontaneous apoptotic tendency was |
| 7808 | NGF | nerve growth factor (beta polypeptide) | nerve growth factor | 1.0 | this is in line with the recent report [ lee et al 2002 ] that aggregation of fals sod1 is not causative of death in nerve growth factor ngf differentiated pc12 cells transfected with mutant sod1s sodmt v148g or a4v . |